Elizabeth Garrett‐Mayer
- Oncology top 0.5%
- Molecular Biology top 2%
- Pulmonary and Respiratory Medicine top 0.5%
- Immunology top 1%
- Cancer Research top 0.5%
- Co-authors
- Rebecca LandaDavid WendlerDavid I. ShalowitzMichael I. NishimuraDavid J. ColeMohamed L. SalemAlberto J. MonteroC. Marcela Díaz‐Montero
- Topics
- Cancer Genomics and Diagnostics (45 papers)Lung Cancer Treatments and Mutations (36 papers)Colorectal Cancer Treatments and Studies (25 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Oncology
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
Elizabeth Garrett‐Mayer
328 papers receiving 12.7k citations
Hit Papers
Peers
Comparison fields: 5 of 181
- Oncology 3.8k
- Molecular Biology 3.3k
- Pulmonary and Respiratory Medicine 2.4k
- Immunology 1.9k
- Cancer Research 1.8k
Countries citing papers authored by Elizabeth Garrett‐Mayer
This map shows the geographic impact of Elizabeth Garrett‐Mayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Garrett‐Mayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Garrett‐Mayer more than expected).
Fields of papers citing papers by Elizabeth Garrett‐Mayer
This network shows the impact of papers produced by Elizabeth Garrett‐Mayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Garrett‐Mayer. The network helps show where Elizabeth Garrett‐Mayer may publish in the future.
Co-authorship network of co-authors of Elizabeth Garrett‐Mayer
This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Garrett‐Mayer. A scholar is included among the top collaborators of Elizabeth Garrett‐Mayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Garrett‐Mayer. Elizabeth Garrett‐Mayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 7 | |
| 6 | 29 | |
| 7 | 44 | |
| 8 | 7 | |
| 9 | 7 | |
| 10 | 58 | |
| 11 | 46 | |
| 12 | 21 | |
| 13 | 39 | |
| 14 | 55 | |
| 15 | 77 | |
| 16 | 5 | |
| 17 | 166 | |
| 18 | 52 | |
| 19 | 282 | |
| 20 | 2 |
About Elizabeth Garrett‐Mayer
Elizabeth Garrett‐Mayer is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 339 papers that have together received 13.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (45 papers), Lung Cancer Treatments and Mutations (36 papers) and Colorectal Cancer Treatments and Studies (25 papers). The work is most often cited by research in Oncology (3.8k citations), Cancer Research (1.8k citations) and Immunology (1.9k citations). Elizabeth Garrett‐Mayer has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Rebecca Landa, David Wendler, David I. Shalowitz, Michael I. Nishimura, David J. Cole, Mohamed L. Salem, Alberto J. Montero, C. Marcela Díaz‐Montero, Mario A. Eisenberger and Katherine C. Holman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.